Company:  REXAHN PHARMACEUTICALS, I ... (RNN)
Form Type:  10-K
Filing Date:  3/31/2010 
CIK:  0001228627 
Address:  15245 SHADY GROVE ROAD, SUITE 455 
City, State, Zip:  ROCKVILLE, Maryland 20850 
Telephone:  (240) 268-5300 
Fiscal Year:  12/31 
Last Trade
Last Trade: 
$0.33   		Change: 
0.005 (1.56%)  
Trade Time: 
May 17   		Market Cap: 
$38.81M
Description of Business
Register for a Free Trial and access this filing in:     
  FORM 10-K
    PART I
      Item 1. Description of Business
      Item 1A. Risk Factors.
      Item 1B. Unresolved Staff Comments.
      Item 2. Description of Property.
      Item 3. Legal Proceedings.
    PART II
      Item 5. Market for Common Equity, Related Stockholder ...
      Item 6. Selected Financial Data.
      Item 7. Management's Discussion and Analysis of Financial ...
        Results of Operations
        Liquidity and Capital Resources
      Item 7A. Quantitative and Qualitative Disclosures About ...
      Item 8. Financial Statements and Supplementary Data.
      Item 9B. Other Information.
    PART III
      Item 10. Directors, Executive Officers and Corporate Governance.
      Item 11. Executive Compensation.
      Item 12. Security Ownership of Certain Beneficial Owners and ...
      Item 13. Certain Relationships and Related Transactions; and ...
      Item 14. Principal Accounting Fees and Services.
    PART IV
      Item 15. Exhibits, Financial Statement Schedules.
    SIGNATURES
    REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
    BALANCE SHEET
    INCOME STATEMENT
    STOCKHOLDERS EQUITY
    STOCKHOLDERS EQUITY
    CASH FLOW
    Notes to the Financial Statements
      INCOME STATEMENT
    EXHIBIT INDEX
    RATIO COMPUTATION
  EXHIBIT 23
    CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
  EXHIBIT 24
    POWER OF ATTORNEY
  EXHIBIT 31.1
    CERTIFICATION
  EXHIBIT 31.2
    CERTIFICATION
  EXHIBIT 32.1
    CERTIFICATION OF
  EXHIBIT 32.2
    CERTIFICATION OF
© 1995-2013 EDGAR Online, Inc. All rights reserved • NASDAQ: EDGR • Solutions for Corporations • Terms of Use • Privacy Statement